vs
PUMA BIOTECHNOLOGY, INC.（PBYI）与Yext, Inc.（YEXT）财务数据对比。点击上方公司名可切换其他公司
Yext, Inc.的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.5倍（$112.0M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs -1.7%），PUMA BIOTECHNOLOGY, INC.自由现金流更多（$14.4M vs $-20.3M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 5.2%）
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
Yext是一家总部位于纽约的软件企业，为多门店品牌提供数字影响力管理平台。品牌可通过该 centralized 平台在整个数字领域为客户提供一致准确的信息，平台涵盖本地商家信息管理、网页搭建、社交媒体运营、声誉管理等多项功能，帮助品牌通过各类数字渠道触达本地客户。
PBYI vs YEXT — 直观对比
营收规模更大
YEXT
是对方的1.5倍
$75.5M
营收增速更快
PBYI
高出29.5%
-1.7%
自由现金流更多
PBYI
多$34.7M
$-20.3M
两年增速更快
PBYI
近两年复合增速
5.2%
损益表 — Q4 FY2025 vs Q3 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $75.5M | $112.0M |
| 净利润 | — | $6.1M |
| 毛利率 | 69.3% | 73.9% |
| 营业利润率 | 22.7% | 6.9% |
| 净利率 | — | 5.5% |
| 营收同比 | 27.7% | -1.7% |
| 净利润同比 | — | 147.9% |
| 每股收益（稀释后） | $0.26 | $0.01 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PBYIYEXT
| Q4 25 | $75.5M | $112.0M | ||
| Q3 25 | $54.5M | $113.1M | ||
| Q2 25 | $52.4M | $109.5M | ||
| Q1 25 | $46.0M | $113.1M | ||
| Q4 24 | $59.1M | $114.0M | ||
| Q3 24 | $80.5M | $97.9M | ||
| Q2 24 | $47.1M | $96.0M | ||
| Q1 24 | $43.8M | $101.1M |
净利润PBYIYEXT
| Q4 25 | — | $6.1M | ||
| Q3 25 | $8.8M | $26.8M | ||
| Q2 25 | $5.9M | $770.0K | ||
| Q1 25 | $3.0M | $-7.3M | ||
| Q4 24 | — | $-12.8M | ||
| Q3 24 | $20.3M | $-4.1M | ||
| Q2 24 | $-4.5M | $-3.8M | ||
| Q1 24 | $-4.8M | $1.7M |
毛利率PBYIYEXT
| Q4 25 | 69.3% | 73.9% | ||
| Q3 25 | 77.7% | 75.2% | ||
| Q2 25 | 76.5% | 75.2% | ||
| Q1 25 | 77.1% | 76.8% | ||
| Q4 24 | 76.4% | 77.0% | ||
| Q3 24 | 63.9% | 77.2% | ||
| Q2 24 | 77.4% | 77.6% | ||
| Q1 24 | 75.5% | 78.6% |
营业利润率PBYIYEXT
| Q4 25 | 22.7% | 6.9% | ||
| Q3 25 | 17.6% | 26.2% | ||
| Q2 25 | 12.7% | 1.0% | ||
| Q1 25 | 8.7% | -8.0% | ||
| Q4 24 | 22.6% | -9.1% | ||
| Q3 24 | 27.4% | -7.7% | ||
| Q2 24 | -4.6% | -5.7% | ||
| Q1 24 | -5.3% | 1.0% |
净利率PBYIYEXT
| Q4 25 | — | 5.5% | ||
| Q3 25 | 16.2% | 23.7% | ||
| Q2 25 | 11.2% | 0.7% | ||
| Q1 25 | 6.5% | -6.4% | ||
| Q4 24 | — | -11.2% | ||
| Q3 24 | 25.2% | -4.1% | ||
| Q2 24 | -9.6% | -4.0% | ||
| Q1 24 | -11.0% | 1.7% |
每股收益（稀释后）PBYIYEXT
| Q4 25 | $0.26 | $0.01 | ||
| Q3 25 | $0.17 | $0.03 | ||
| Q2 25 | $0.12 | $0.01 | ||
| Q1 25 | $0.06 | $-0.06 | ||
| Q4 24 | $0.40 | $-0.10 | ||
| Q3 24 | $0.41 | $-0.03 | ||
| Q2 24 | $-0.09 | $-0.03 | ||
| Q1 24 | $-0.10 | $0.01 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $97.5M | $139.9M |
| 总债务越低越好 | $22.7M | $98.2M |
| 股东权益账面价值 | $130.3M | $155.2M |
| 总资产 | $216.3M | $555.8M |
| 负债/权益比越低杠杆越低 | 0.17× | 0.63× |
8季度趋势，按日历期对齐
现金及短期投资PBYIYEXT
| Q4 25 | $97.5M | $139.9M | ||
| Q3 25 | $94.4M | $178.8M | ||
| Q2 25 | $96.0M | $115.0M | ||
| Q1 25 | $93.2M | $123.1M | ||
| Q4 24 | $101.0M | $100.5M | ||
| Q3 24 | $96.7M | $234.8M | ||
| Q2 24 | $96.8M | $246.1M | ||
| Q1 24 | $107.2M | $210.2M |
总债务PBYIYEXT
| Q4 25 | $22.7M | $98.2M | ||
| Q3 25 | $34.0M | $98.3M | ||
| Q2 25 | $45.3M | — | ||
| Q1 25 | $56.7M | $0 | ||
| Q4 24 | $68.0M | — | ||
| Q3 24 | $79.3M | — | ||
| Q2 24 | $90.7M | — | ||
| Q1 24 | $102.0M | — |
股东权益PBYIYEXT
| Q4 25 | $130.3M | $155.2M | ||
| Q3 25 | $115.3M | $152.5M | ||
| Q2 25 | $104.7M | $142.0M | ||
| Q1 25 | $97.1M | $153.2M | ||
| Q4 24 | $92.1M | $160.0M | ||
| Q3 24 | $71.1M | $162.8M | ||
| Q2 24 | $48.5M | $155.7M | ||
| Q1 24 | $51.0M | $147.2M |
总资产PBYIYEXT
| Q4 25 | $216.3M | $555.8M | ||
| Q3 25 | $202.9M | $626.2M | ||
| Q2 25 | $194.9M | $572.4M | ||
| Q1 25 | $196.2M | $610.1M | ||
| Q4 24 | $213.3M | $540.3M | ||
| Q3 24 | $220.7M | $458.2M | ||
| Q2 24 | $205.0M | $481.7M | ||
| Q1 24 | $214.1M | $508.8M |
负债/权益比PBYIYEXT
| Q4 25 | 0.17× | 0.63× | ||
| Q3 25 | 0.30× | 0.64× | ||
| Q2 25 | 0.43× | — | ||
| Q1 25 | 0.58× | 0.00× | ||
| Q4 24 | 0.74× | — | ||
| Q3 24 | 1.12× | — | ||
| Q2 24 | 1.87× | — | ||
| Q1 24 | 2.00× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-19.8M |
| 自由现金流经营现金流 - 资本支出 | $14.4M | $-20.3M |
| 自由现金流率自由现金流/营收 | 19.1% | -18.2% |
| 资本支出强度资本支出/营收 | 0.0% | 0.5% |
| 现金转化率经营现金流/净利润 | — | -3.23× |
| 过去12个月自由现金流最近4个季度 | $41.7M | $62.7M |
8季度趋势，按日历期对齐
经营现金流PBYIYEXT
| Q4 25 | $14.4M | $-19.8M | ||
| Q3 25 | $9.7M | $8.4M | ||
| Q2 25 | $14.1M | $37.7M | ||
| Q1 25 | $3.6M | $38.3M | ||
| Q4 24 | $15.6M | $-15.8M | ||
| Q3 24 | $11.0M | $-10.6M | ||
| Q2 24 | $1.0M | $38.3M | ||
| Q1 24 | $11.2M | $28.0M |
自由现金流PBYIYEXT
| Q4 25 | $14.4M | $-20.3M | ||
| Q3 25 | $9.7M | $7.8M | ||
| Q2 25 | $14.1M | $37.2M | ||
| Q1 25 | $3.6M | $38.0M | ||
| Q4 24 | $15.6M | $-16.4M | ||
| Q3 24 | $11.0M | $-11.2M | ||
| Q2 24 | $1.0M | $37.7M | ||
| Q1 24 | — | $27.6M |
自由现金流率PBYIYEXT
| Q4 25 | 19.1% | -18.2% | ||
| Q3 25 | 17.7% | 6.9% | ||
| Q2 25 | 26.8% | 33.9% | ||
| Q1 25 | 7.7% | 33.6% | ||
| Q4 24 | 26.4% | -14.4% | ||
| Q3 24 | 13.7% | -11.4% | ||
| Q2 24 | 2.1% | 39.2% | ||
| Q1 24 | — | 27.3% |
资本支出强度PBYIYEXT
| Q4 25 | 0.0% | 0.5% | ||
| Q3 25 | 0.0% | 0.5% | ||
| Q2 25 | 0.0% | 0.5% | ||
| Q1 25 | 0.1% | 0.3% | ||
| Q4 24 | 0.0% | 0.5% | ||
| Q3 24 | 0.0% | 0.6% | ||
| Q2 24 | 0.0% | 0.7% | ||
| Q1 24 | 0.0% | 0.4% |
现金转化率PBYIYEXT
| Q4 25 | — | -3.23× | ||
| Q3 25 | 1.10× | 0.31× | ||
| Q2 25 | 2.41× | 48.99× | ||
| Q1 25 | 1.21× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.54× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 16.61× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
